Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ ...
Blood-pressure reduction is the only proven treatment to prevent stroke. Whether a single pill that combines three ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results